Executive Order – Ensuring American Pharmaceutical Supply Chain Resilience by Filling the Strategic Active Pharmaceutical Ingredients Reserve
The White House has issued an executive order aimed at securing the supply chain of Active Pharmaceutical Ingredients (APIs), i.e., the biologically active components in finished drug products.
🔒 Members Only · Transforming Procurement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every case digest, six days a week.
$750/year